The Heart-Lung Connection: Managing Cardiovascular Risk in People Living with COPD

This post was written by Arnelle Konde, MPH, CHES.

Cardiovascular disease (CVD) is one of the most common and significant comorbidities affecting outcomes for people living with COPD.¹ Because COPD frequently coexists with other chronic conditions, recognizing and addressing cardiovascular health is a critical component of comprehensive care.

Health care professionals play a key role in identifying cardiovascular risk factors and helping patients understand the connection between heart and lung health. Open conversations combined with evidence-based management can empower patients to better navigate their condition and improve their quality of life.

Why Screening for Heart Health Matters

CVD is one of the leading causes of morbidity in people living with COPD.^1,2 The heart and lungs are deeply interconnected. COPD can place additional stress on the cardiovascular system through changes in breathing, oxygen levels, inflammation, and blood flow.² Given the high burden of CVD in COPD, routine assessment and management of cardiovascular risk should be incorporated into ongoing care.^2,3 Cardiovascular comorbidities in COPD are associated with increased mortality, more frequent hospitalizations, and greater health care costs, highlighting the need for proactive CVD screening and management.^1,9

How the Heart and Lungs Overlap

Shared risk factors, including age, tobacco smoke exposure, physical inactivity, and systemic inflammation contribute to both airway and vascular damage.^3,4

These overlapping mechanisms can create several clinical challenges:

• Symptom Overlap: Shortness of breath, difficulty exercising, and fatigue are major signs of both COPD and cardiovascular conditions.^2,3 Determining whether worsening short of breath is driven by airway obstruction, heart strain, or a combination of both requires ongoing evaluation.²
• Exacerbation-Cardiac Link: Acute COPD exacerbations affect more than the respiratory system and can place significant stress on the heart. Respiratory exacerbations and accompanying systemic inflammation are linked to an increased short-term risk of a heart attack and stroke in the days and weeks following a flare-up.^4,5

Key Cardiovascular Conditions to Watch For

Health care teams should routinely monitor cardiovascular conditions that commonly coexist with COPD, including:

• Left-Sided Heart Failure: Can cause symptoms such as shortness of breath and fatigue that overlap with COPD symptoms, complicating diagnosis and management.^2,8
• Right-Sided Heart Failure:
• Can develop when COPD leads to high blood pressure in the lungs (pulmonary hypertension), causing fluid buildup, swelling in the legs and ankles, and decreased exercise tolerance.⁹
• Ischemic Heart Disease: Coronary artery disease often presents atypical or less apparent in individuals whose physical activity is limited by shortness of breath.^2,3
• Arrhythmias: Atrial fibrillation and other irregular heart rhythms are frequently triggered by systemic hypoxia, altered chest mechanics, and autonomic strain.⁴

Evidence-Based Management of COPD and CVD

Managing CVD and COPD can present clinical challenges, especially when questions arise around medication safety and treatment optimization.^1,6 Health care teams can optimize dual management by focusing on evidence-based strategies:

Debunking Beta-Blocker Hesitancy

Historically, beta-blockers have been underutilized in patients with COPD because of concerns about causing narrow airways and worsening respiratory symptoms.⁶ However, evidence indicates that cardioselective beta-blockers, such as metoprolol succinate or bisoprolol, are generally safe, well tolerated, and do not negatively affect lung function.⁶ When indicated for conditions such as heart failure or post-heart attack care, cardioselective beta-blockers should remain part of the treatment plan.^1,5-6

Dual-Benefit Preventative Interventions

Several non-pharmacological interventions have proven to be effective for cardiovascular health in COPD patients:

• Cardiopulmonary Rehabilitation and Exercise: Regular exercise and pulmonary rehabilitation can improve blood flow, enhance oxygen delivery, lower blood pressure, and strengthen respiratory muscles.¹
• Smoking Cessation: For patients with smoking history, quitting is the most effective intervention to slow COPD progression while significantly reducing cardiovascular risk.^3,7
• Vaccinations: Routine vaccination against influenza, pneumococcal disease, COVID-19, and RSV can help prevent respiratory infections and reduce the inflammation that can trigger cardiovascular events.⁴

Action Steps for the Clinical Team

Integrating cardiovascular assessment into routine COPD care can be achieved through several practical steps:

1. Review Medications: Confirm that patients with co-existing cardiac conditions are receiving appropriate cardioselective beta-blockers and using inhaled therapies as prescribed.^1,5
2. Reinforce Preventive Care: Emphasize the heart and lung benefits of annual vaccinations, regular physical activity, and smoking cessation.^3,7
3. Coordinate Across Specialties: Maintain clear communication among primary care providers, pulmonologists, and cardiologists to keep treatment plans aligned.

Recognizing the close relationship between the heart and lungs supports a more proactive and comprehensive approach to COPD management. By addressing cardiovascular health along with respiratory symptoms, clinicians can help prevent avoidable complications and support better long-term health outcomes.